Literature DB >> 728348

Cell yield and cell survival following chemotherapy of the B16 melanoma.

T C Stephens, J H Peacock.   

Abstract

We describe in this paper cell survival studies, using in vitro clonogenic assays, performed on the B16 melanoma treated in situ with various cytotoxic agents. In addition we have determined the effects of these agents on the yield of cells obtained by trypsinization. In untreated tumours the mean cell yield was approximately 10(8)/g, which is 20--30% of the cells actually present in the tissue. The plating efficiency was approximately 40%. Most agents rapidly affected both cell yield and cell survival. For example, within 20--30 h, gamma-radiation and several alkylating agents reduced cell yield by about 40%. The cell yield change was associated with an increase in mean cell size. Cell yield was reduced even more (approximately 70%) by Vinca alkaloids. This large reduction was associated with extensive cell lysis, observed as an increase in the necrotic fraction of tumours from approximately 35% to approximately 70%. Adriamycin, bleomycin and Ara-C also produced a moderate reduction in cell yield (approximately 40%), but actinomycin D did not reduce cell yield and FU increased it by about 30%. Only gamma-radiation, cyclophosphamide, CCNU, BCNU and melphalan produced more than a 90% reduction in cell survival, although there was a small but measurable reduction with all other agents except vinblastine, HN2 and actinomycin D.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728348      PMCID: PMC2009784          DOI: 10.1038/bjc.1978.254

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  A microchemical determination of desoxyribonucleic acid.

Authors:  G CERIOTTI
Journal:  J Biol Chem       Date:  1952-09       Impact factor: 5.157

2.  Giant histiocytes after cyclophosphamide.

Authors:  G Castaldi; G Zavagli; O Fiocchi; F Trotta
Journal:  Experientia       Date:  1970-03-15

3.  Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures.

Authors:  G W Barendsen; J J Broerse
Journal:  Eur J Cancer       Date:  1969-09       Impact factor: 9.162

4.  A cell dispersion technique for use in quantitative transplantation studies with solid tumours.

Authors:  H S Reinhold
Journal:  Eur J Cancer       Date:  1965-06       Impact factor: 9.162

5.  In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy.

Authors:  M L Rosenblum; K D Knebel; D A Vasquez; C B Wilson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

6.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

7.  Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.

Authors:  T C Stephens; J H Peacock; G G Steel
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

  7 in total
  15 in total

1.  A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors.

Authors:  Nelita T Elliott; Fan Yuan
Journal:  Biotechnol Bioeng       Date:  2011-12-26       Impact factor: 4.530

Review 2.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 3.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

4.  Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.

Authors:  X H Li; G Paulus; G Atassi; N Buyssens
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

Review 5.  Experimental chemotherapy studies: intercomparison of assays.

Authors:  P R Twentyman
Journal:  Br J Cancer Suppl       Date:  1980-04

Review 6.  Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity.

Authors:  G W Barendsen
Journal:  Br J Cancer Suppl       Date:  1980-04

7.  Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.

Authors:  M Schabet; P Ohneseit; R Buchholz; L Santo-Höltje; H Schmidberger
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

8.  An appraisal of in vivo assays of excised tumours.

Authors:  R P Hill
Journal:  Br J Cancer Suppl       Date:  1980-04

9.  CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.

Authors:  Sadna Budhu; John D Loike; Ashley Pandolfi; Soo Han; Geoffrey Catalano; Andrei Constantinescu; Raphael Clynes; Samuel C Silverstein
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

10.  Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.

Authors:  T C Stephens; V D Courtenay; J Mills; J H Peacock; C M Rose; D Spooner
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.